Cancer Trials
To request more information on clinical trials please fill out our request information form.
Disease Site | Study | Location |
---|---|---|
Disease Site: Breast | ALLIANCE A011202 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | Acerta ACE-LY-003 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Colon | ALLIANCE A021502/ATOMIC View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Colorectal | Alliance A021703 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Pancreatic | Alliance A021806 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Germ Cell Tumors | Alliance A031102 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Renal | Alliance A031704 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: ALL | ALLIANCE A041501 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: AML | Alliance A041701 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: CLL | Alliance A041702 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | ALLIANCE A051301 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lung: Non-Small Cell | ALLIANCE A151216 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | Alliance A171901 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | Alliance A191901 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: | Alliance A221805 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Breast | Alliance Foundation Trials AFT 25 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Gastric/GE Junction | Astellas 8951-CL-0302 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | BeiGene BGB 3111-306 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Solid Tumors | Cancer Moonshot Biobank Research Protocol View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Breast | CTSU CCTG MA.39 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: | CTSU EA1151 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Head & Neck | CTSU EA3161 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | CTSU EA4151 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | CTSU EA4181 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lung: Non-Small Cell | CTSU EA5163 INSIGNA View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Melanoma | CTSU EA6134 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: CML | CTSU EA9171 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Multiple Myeloma | CTSU EAA173 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Solid Tumors | CTSU EAY131 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: AML | Delta-Fly Pharma, Inc. D18-11141 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | ECOG ACRIN E4412 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Survivorship | ECOG ACRIN EA2185 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: ALL | ECOG ACRIN EA9181 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: MDS | Forty Seven 5F9009 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Cervical | GOG 0263 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Ovarian | GOG 3018 (VB-111-701) View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | INCYTE INCMOR0208-301 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Mult Myeloma | Janssen 54767414MMY3021--ESO only View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: | NCI COVID-19 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Melanoma | Nektar 20-214-29/CA045-022 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Hematologic Malignancies | NMDP Database Protocol View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: | NMDP Repository Protocol View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Brain | NRG BN007 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Brain | NRG BN009 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Breast | NRG BR003 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Breast | NRG BR004 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | NRG CC003 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Prostate | NRG CC007CD View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | NRG CC008 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Uterus,Cervix or Vaginal | NRG GY006 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Endometrial | NRG GY018 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Endometrial | NRG GY020 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Head & Neck | NRG HN005 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lung: Non-Small Cell | NRG LU002 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lung:Small Cell | NRG LU007 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Liver | Nucana NuTide 121 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Mesothelioma | Optune Lua/NovoTTF-100L System View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Multiple Myeloma | Pfizer C1071003 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Pancreatic | Renovo TIGeR-PaC View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Melanoma | Replimune RPL-002-18 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Head & Neck | RTOG 1216 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Multiple Myeloma | Sanofi OBS16577/IONA-MM View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Solid Tumors | Seagen SGNTUC-019 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | Seattle Genetics SGN35-031 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lung: Non-Small Cell | SWOG LungMAP View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | SWOG S1501 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Solid Tumors | SWOG S1609 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Thymic | SWOG S1701 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Breast | SWOG S1703 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Breast | SWOG S1706 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: CML | SWOG S1712 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | SWOG S1714 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Prostate | SWOG S1802 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Bladder | SWOG S1806 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | SWOG S1820 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Germ Cell Tumors | SWOG S1823 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | SWOG S1826 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Colon | SWOG S1922 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Renal | SWOG S1931 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | URCC 16070 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | URCC 16092 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | URCC 18007 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | URCC 19085 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lymphoma | USO 11282/Seattle Genetics SGN35-015 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: AML | USO 18168/AbbVie M19-072 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Prostate | USO 19144/Janssen 64091742PCR0002 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: CLL | USO 19205 ULTRA-V View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Lung: Non-Small Cell | USO 20137/ Roche GO41854 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Survivorship | USO 20157/FRNM-004 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Prostate | USO 20248/Janssen 67652000PCR3002 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | WF 1801 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Prostate | WF 1802 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Care Delivery | WF 1805CD View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | WF 1806 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | WF 1901 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Treatment | Alliance A011801 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Treatment | Alliance A031902 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Supportive Care | SWOG S1912CD View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Treatment | Gilead Sciences GS-US-546-5857 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Treatment | Instylla INY-P-20-001 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Treatment | Celgene BB2121 EAP 001 View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Treatment | Novartis CTL019B2003I View on ClinicalTrials.gov | OP Cancer Institute Research 864-241-6251 |
Disease Site: Solid Tumors or Lymphoma | Adlai Nortye AN4005X0101 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Lung:Small Cell | Amgen 20160323 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Lymphoma | Aptose APTO-CG-806-01 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Colon | Arcus ARC-9 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | AstraZeneca Rare Tumor (ESR-15-11633) View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Lung:Small Cell | BioNTech BNT411-01 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Multiple Myeloma | Celgene CC-220-MM-001 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Lymphoma | Cellectar DCL-16-001 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Compass CTX-471-001 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Lymphoma | Genmab GCT3013-01 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Multiple Myeloma | GSK 207497 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Hookipa H-200-001 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Lymphoma | Hutchison 2018-523-00US1 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | ImmVira MVR-T3011-003 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Jounce Therapeutics, Inc., JTX-8064-101 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Prostate | Laekna Limited LAE201INT2101 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Mersana XMT-1536 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Pancreatic | NGM 18-0402 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | NGM707-IO-101 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Shanghai EpimAb EMB02X101 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Shanghai Miracogen MRG002-001 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Tarveda PEN-866-001 (Refmal 492) View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | Tizona TTX-030-002 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Breast | USO 17194 Inventis View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | USO 18057 BMS CA030001 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | USO 18183 Bayer View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | USO 18188 TP-1287-101 View on ClinicalTrials.gov | ITOR 864-455-3600 |
Disease Site: Solid Tumors | USO 20414 Hutchison 2020-012-GLOB1 View on ClinicalTrials.gov | ITOR 864-455-3600 |